出处
《四川医学》
CAS
2008年第4期464-466,共3页
Sichuan Medical Journal
基金
四川省科技厅基金资助(项目编号05JY029-039)
参考文献16
-
1Liu Q, Ohshima K, Kikuehi M. High expression of MDR-1 gene and P-glycoprotein in initial and re-biospy specimens of relapsed B-cell lymphoma [J]. Histopathology, 2001,38(3) :209 - 216
-
2Plasschaert SL, Vellenga E,de Bont ES, et al. High functional P-glycoprorein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children[J]. Leuk Lymphoma,2003,44( 1 ) :85 - 95
-
3Steinbach D, Wittig S, Crio G, et ol.The multidrug resistance-associated protein3(MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis inmale patients and T-cell immunophenotype[ J ]. Blood, 2003,102(13) : 4493 - 4498
-
4Van der Kolk DM, de Vries EG, Noordhoek L, et al. Activity and expression of the multidrug resistance proteins P-glycoprotein, MRPI, MRP2, MRP3 and MRP5 in denovo and relapsed acute myeloid leukemia[ J]. Leukemia, 2001,15(10) : 1544 - 1553
-
5Plasschaert SL, de Bont ES, Boezen M, et al. Expression of muhidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia[ J]. Clin Cancer Res, 2005, 11 (24 Pt1 ) : 8661 - 8668
-
6Valera ET, Scrideli CA, Queiroz Rg, et al. Multiple drug resistance protein ( MDR-1 ), multidrug resistance-related protein (MRP) and lung resistance protein(LRP) gene expression in childhood acute lymphoblastic leukemia [J] .Sao Paulo Med J,2004,122(4) : 166 - 177
-
7Huh H J, Park CJ,Jang S, et al. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein(MRP) and lung resistance protein(LRP)mRNA expression in acute leukemia[J]. J Korean Med Sci,2006,21(2) :253 - 258
-
8Van den Heuvel Eibrink MM,Wiemer EA, Prins A, et al. Increased expression of the hreast cancer resistance protein(BCRP)in relapsed or refractory acute myeloid leukemia (AML) [ J ]. Leukemia, 2002, 16 ( 5 ) : 833 - 839
-
9Gadducci A, Cosio S, Muraca S, et al. Molecullar mechanisms of apoptosis and chemosensitivity to platinum end paclitaxel in ovarian cancer: biological data sad clinical implications[J]. Eur J Gynaecol Oncol,2002,23(5) : 390 - 396
-
10Holleman A, den Boer ML, de Menezes RX, et al. The exression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance,and outcome in childhood acute lymphoblastic leukemia[J]. Blood, 2006,107(2) :769 - 776
同被引文献27
-
1何莉,侯克佐.bcl-2,MDR1基因及编码蛋白在儿童急性白血病骨髓单个核细胞中表达的研究[J].中国医科大学学报,2004,33(5):463-465. 被引量:1
-
2刘筱梅,徐酉华,于洁,邓兵,苏庸春.儿童急性白血病survivin,bcl-2,mdr1的表达及意义[J].重庆医科大学学报,2006,31(2):215-218. 被引量:6
-
3张伟,张丽达,汪爱国,黄培林.高压氧对结肠癌LoVo细胞周期的影响[J].中华航海医学与高气压医学杂志,2006,13(2):88-91. 被引量:8
-
4王丹,克晓燕,胡永芳.MDR1基因多态性及表达与急性白血病患者预后相关性的研究进展[J].中国药理学通报,2007,23(6):707-710. 被引量:3
-
5Efferth T, Sauerbrey A, Steinbach D, et al. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia [J]. Int JOncol, 2003, 23(2): 509-517.
-
6Plasschaert SL, Groninger E, Boezen M, etal. Influence of ftmctional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia [J]. Clin Pharmacol Ther, 2004, 76(3): 220-229.
-
7Hattori H, Suminoe A, Wada M, et al. Regulatory polymor- phisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leuke- mia[J].LeukRes, 2007, 31(12): 1633-1640.
-
8Jamroziak K, Mynarski W, Balcerczak E, et al. Functional C3435T polymorphism ofMDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lympho- blastic leukemia [J]. EurJHaematol, 2004, 72(5): 314-321.
-
9Leal-Ugarte E, Guti6rrez-Angulo M, Macias-G6mez NM, et al. MDRI C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals [J]. HumBiol, 2008, 80(4): 449-455.
-
10Rao DN, Anuradha C, Vishnupriya S, et al. Association of anMDR1 gene (C3435T) polymorphism with acute leukemia in India[J].AsianPacJCancerPrev, 2010, 11(4): 1063-1066.
引证文献2
-
1孙蓬蓬,田霞,张丽萍,陆关法,辛沂青,王培嵩.高压氧辅助治疗急性白血病的研究进展[J].中华航海医学与高气压医学杂志,2010,17(5):320-320.
-
2谭静,谭利娜,张耀东,代志鹏.多药耐药基因C3435T多态性与儿童急性淋巴细胞白血病发生的meta分析[J].临床儿科杂志,2012,30(10):989-993. 被引量:1
-
1王健,谷文光,董志伟.microRNA在癌细胞与肿瘤微环境之间的作用[J].中国矫形外科杂志,2016,24(17):1597-1599. 被引量:2
-
2许文林,江云伟,王法春,袁伟,阮长耿.白血病细胞多药耐药与细胞凋亡的关系[J].白血病.淋巴瘤,2003,12(6):351-353. 被引量:3
-
3方莉莉,许文林,陈琛,房新建,陈巧云,李娟.shRNA干扰VEGF表达对白血病细胞多药耐药的影响[J].江苏大学学报(医学版),2009,19(3):220-224. 被引量:1
-
4张百红,岳红云.肿瘤分子靶向药物的耐药机制[J].肿瘤,2015,35(8):926-929. 被引量:3
-
5李守娟,顾健.DNA拓扑异构酶和端粒酶与白血病多药耐药关系[J].中国实验血液学杂志,2007,15(1):207-210. 被引量:4
-
6李跃晨,王永栋.子宫肌瘤中ER、PR和EGFR的表达及意义[J].河北医药,2009,31(12):1474-1475. 被引量:7
-
7徐磊.白血病细胞多药耐药的凋亡机制及其对策[J].实用肿瘤杂志,2001,16(4):284-287.
-
8范文,罗成燕,程文俊.GRP78在肿瘤发生发展及化疗耐药中的作用[J].国际肿瘤学杂志,2014,41(6):408-411.
-
9孙海英,李德志,徐开林,李振宇,曾令宇,鹿群先.硼替佐米对白血病K562/A02细胞药物增敏效应的实验研究[J].中华血液学杂志,2009,30(1):58-60. 被引量:2
-
10宋启斌,褚玉新,胡钦勇.肿瘤微环境变化在肿瘤免疫耐受中的作用[J].中国肿瘤,2016,25(10):794-798. 被引量:13